Hematopoietic Stem Cell Culture Medium Using GDH Inhibition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for culturing hematopoietic stem cells face challenges in maintaining and proliferating them in vitro due to safety concerns, low efficiency, and high costs, particularly when using demethylating agents that affect epigenetics.

Innovation Solution

A culture medium containing a glutamate dehydrogenase inhibitor, such as R162, is used to maintain and proliferate hematopoietic stem cells, with the inhibitor inactivating glutamate dehydrogenase to preserve the EPCR High phenotype, which is associated with long-term bone marrow reconstruction ability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If a demethylating agent is added to increase amplification efficiency, then the amplification efficiency of hematopoietic stem cells is improved, but epigenetic safety is worsened

Engineering Contradiction:
Improveamplification efficiencyVSAvoidepigenetic disruption
Core Design Contradiction:
ProductivityVSObject-affected harmful factors

Solution Approach 1:

The invention changes the biochemical parameter by targeting glutamate dehydrogenase activity instead of using demethylating agents. By inhibiting glutamate dehydrogenase with specific compounds (e.g., R162, EGCG), the patent achieves amplification through metabolic modulation rather than epigenetic modification, thus improving productivity while avoiding harmful epigenetic effects

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention introduces an intermediary substance (glutamate dehydrogenase inhibitor) that mediates between the desired amplification effect and the avoidance of direct epigenetic disruption. The inhibitor acts as a mediator that achieves cell proliferation through metabolic pathway modulation rather than directly affecting DNA methylation or chromatin structure

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If hematopoietic stem cells are cultured under normal conditions, then the cells are maintained, but most cells differentiate and stem cell activity is weakened

Engineering Contradiction:
Improvestem cell maintenanceVSAvoidstem cell proliferation
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The invention changes the metabolic parameter by inhibiting glutamate dehydrogenase, which shifts the cellular metabolism to preserve stem cell characteristics. This parameter change prevents differentiation and maintains stem cell activity while enabling proliferation, resolving the contradiction between maintenance reliability and productivity

Inventive Principle:
Principle #35Parameter changes

3Productivity

If expansion culture is performed to increase stem cell numbers, then amplification efficiency is improved, but safety and reproducibility are worsened

Engineering Contradiction:
Improveamplification efficiencyVSAvoidsafety and reproducibility
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The invention changes the biochemical parameter to glutamate dehydrogenase inhibition, which provides a safer and more reproducible mechanism for expansion. By using metabolic pathway modulation instead of epigenetic agents or other expansion methods, the patent achieves improved safety and reproducibility while maintaining amplification efficiency

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention substitutes the mechanical/chemical mechanism of demethylating agents with a metabolic mechanism (glutamate dehydrogenase inhibition). This substitution replaces a harmful mechanism with a safer metabolic pathway modulation, improving both safety and reproducibility while maintaining productivity

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The culture medium effectively maintains and amplifies hematopoietic stem cells with a high EPCR phenotype, enhancing their self-replication and differentiation capabilities while minimizing epigenetic disruption and maintaining stem cell activity.

Implementation Method 1

a glutamate dehydrogenase inhibitor as an active ingredient... the glutamate dehydrogenase inhibitor is R162 or a derivative thereof... in which the glutamate dehydrogenase inhibitor is R162 or a derivative thereof

Methodology Applied
Scientific EffectEnzyme inhibition: Enzyme

Data Source

PatentEP4653523A1Culture medium, production method, and cell preparation
Publication Date: 2025.11.26 NAT UNIV CORP KUMAMOTO UNIV
  • EP4653523A1 patent drawingFigure 1
  • EP4653523A1 patent drawingFigure 2
  • EP4653523A1 patent drawingFigure 3

AI summary

There is provided a culture medium for expansion culture of a mammalian hematopoietic stem cell, where the culture medium contains a glutamate dehydrogenase inhibitor as an active ingredient.